These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4813395)

  • 1. Letter: Positive interference by cephalothin with Zimmerman reaction for 17-ketosteroids.
    King A
    Clin Chem; 1974 Mar; 20(3):401-2. PubMed ID: 4813395
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone, 17-hydroxycorticosteroid, 17-ketosteroid, and fluid and electrolyte responses to starvation and selective refeeding.
    Haag BL; Reidenberg MM; Shuman CR; Channick BJ
    Am J Med Sci; 1967 Nov; 254(5):652-8. PubMed ID: 6057075
    [No Abstract]   [Full Text] [Related]  

  • 3. Titration of hormone metabolites in cases of nasopharyngeal angiofibroma five years after the operation.
    Karatay S; Katircioglu S; Erözden O
    Acta Otolaryngol; 1969; 67(2):97-100. PubMed ID: 4315884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on the urinary excretion of aldosterone in myasthenia gravis].
    Nakamoto M
    Nihon Naibunpi Gakkai Zasshi; 1967 Nov; 43(8):770-84. PubMed ID: 5626257
    [No Abstract]   [Full Text] [Related]  

  • 5. [Excretion of adrenal steroids in relation to alimentation and posture changes].
    Drafta D; Belloiu DD; Oprescu M; Augustin M; Cristoveanu A; Bunea M; Drăguşanu M
    Stud Cercet Endocrinol; 1968; 19(4):295-301. PubMed ID: 5686801
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of sodium homeostasis in children with recurrent urinary tract infections and reduced glomerular filtration rates.
    Aperia A; Berg U; Broberger O
    Acta Paediatr Scand; 1971 Nov; 60(6):695-704. PubMed ID: 5123499
    [No Abstract]   [Full Text] [Related]  

  • 7. [Salt losing syndrome due to selective hypoaldosteronism (author's transl)].
    Méndez Aparicio M
    An Esp Pediatr; 1975; 8(4):435-42. PubMed ID: 167629
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromatographic separation of 17-ketosteroids and 17-hydroxycorticosteroids on sephadex LH-20.
    Seki T; Sugase T
    J Chromatogr; 1969 Jul; 42(4):503-8. PubMed ID: 4240909
    [No Abstract]   [Full Text] [Related]  

  • 9. Interference of spironolactone in 17-hydroxycorticoid and 17-ketosteroid determinations.
    Desper PC; Flink EB; Jones JE
    Metabolism; 1966 Sep; 15(9):823-7. PubMed ID: 5929038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary hypoaldosteronism caused by a probable anomaly of 18-hydroxylation].
    Jean R; Legrand JC; Meylan F; Rieu D; Astruc J
    Arch Fr Pediatr; 1969; 26(7):769-77. PubMed ID: 5355252
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference in the Zimmerman test for steroids.
    Richardson RA
    Clin Chim Acta; 1974 Jan; 50(1):151-2. PubMed ID: 4150218
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of sodium intake on prostaglandin A, renin and aldosterone in normotensive humans.
    Payakkapan W; Attallah AA; Lee JB; Carr AA
    Kidney Int Suppl; 1975 Sep; ():S283-90. PubMed ID: 1059808
    [No Abstract]   [Full Text] [Related]  

  • 13. [Excretion of adrenal hormones in patients with congestive circulatory insufficiency].
    Kukes VG; Men'shikov VV; Bass ZhZh; Shekhter IM; Anastas'ina GV
    Kardiologiia; 1970 Feb; 10(2):72-8. PubMed ID: 5428120
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of total, grouped, and individual urinary 17-ketosteroids: a critical evaluation.
    Matthijssen C; Goldzieher JW
    Acta Endocrinol (Copenh); 1971 Oct; 68(2):311-33. PubMed ID: 4331245
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressed plasma renin activity in hypertension.
    Channick BJ; Adlin EV; Marks AD
    Arch Intern Med; 1969 Feb; 123(2):131-40. PubMed ID: 4303266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension with inappropriate aldosterone stimulation.
    Christlieb AR; Hickler RB; Lauler DP; Williams GH
    N Engl J Med; 1969 Jul; 281(3):128-31. PubMed ID: 4307140
    [No Abstract]   [Full Text] [Related]  

  • 18. The circadian periodicity of urinary 17-ketosteroids, corticosteroids, and electrolytes in congenital adrenal hyperplasia.
    Meyer WJ; Diller EC; Bartter FC; Halberg F
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1122-7. PubMed ID: 993315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the renin-aldosterone system in congenital adrenal hyperplasia.
    Strickland AL; Kotchen TA
    J Pediatr; 1972 Nov; 81(5):962-9. PubMed ID: 5086723
    [No Abstract]   [Full Text] [Related]  

  • 20. [The dose dependent adrenocorticotropic effect of beta-1-24-corticotropin in comparison with natural ACTH].
    Weissbecker L; Schemmel K; Leybold K
    Arztl Forsch; 1967 Oct; 21(10):385-8. PubMed ID: 4299037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.